Takeda set to divest $400m Irish facility
The facility was completed prior to Takeda’s acquisition of Shire and is now deemed surplus to requirements.
Archives for February 4, 2020
FairJourney lands GHO investment to expand antibody discovery services
GHO Capital invests in FairJourney Biologics to fund expansion of antibody discovery services.